Skip to main content
. Author manuscript; available in PMC: 2024 Nov 15.
Published in final edited form as: Bioorg Med Chem. 2023 Sep 30;95:117487. doi: 10.1016/j.bmc.2023.117487

Scheme 5.

Scheme 5.

Reagents and conditions: (a) Pyridine-sulfur trioxide complex, NEt3, DCM, DMSO, 60%; (b) Bestmann-Ohira reagent, K2CO3, MeOH, 72%; (c) 4-fluorobenzaldehyde oxime, PIFA, MeOH, H2O, 52%; (d) 4M HCl in 1,4-dioxane, 100%; (e) 2-ethoxybenzene sulfonyl chloride, DIEA, DCM, 55%; (f) 1-azido-4-fluorobenzene, sodium ascorbate, CuSO4, tert-BuOH, H2O, 56%; (g) 4M HCl in 1,4-dioxane, 100%; (h) 2-ethoxybenzene sulfonyl chloride, NEt3, DCM, 31%.